NR3C1 and pancreatic neoplasm: Another study demonstrated that knockdown or drug inhibition of the glucocorticoid receptor (GR) facilitated the increasing expression of MHC-I, thereby enhancing the infiltration of CTLs and the sensitivity of pancreatic cancer to immune checkpoint blockade 51.